Therapy of Preconditioned Autologous BMMSCs for Patients With Ischemic Heart Disease

A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT02504437

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 1/2
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02504437
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02504437. Randomized; double masking; primary purpose treatment. Start 2015-11 (registry gives no type); primary completion 2017-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Therapy of Preconditioned Autologous BMMSCs for Patients With Ischemic Heart Disease
Acronym
TPAABPIHD
Condition
Acute Myocardial Infarction
Condition
Ischemic Cardiomyopathy
Intervention (Biological)
BMMSCs
Lead sponsor
Academy Military Medical Science, China (class: industry)
Collaborator
Sun Yat-sen University (class: other)

Record details

Record id
cardio:ct-nct02504437
Content hash
fd93b4ff54f4819a6ef9c3622925b9d9f7137eef4fb4bb5af9a4834a6fbce625